HealthTrust presents… “Antimicrobial Stewardship Pearls: Antibiotic Treatment and Prophylaxis Duration” Download a PDF of this presentation Listen to a recording of this session On both a national and global level, the World Health Organization, The Joint Commission and the United States government have identified antimicrobial stewardship to be an issue of utmost importance. As healthcare […]
Medscape presents… “Biomarker-driven Management of Sepsis and Antibiotics: Evidence and Perspectives” Authors: Robert A. Balk, M.D., Thomas Ahrens, PhD, RN, John A. Bosso, PharmD, and Eric Gluck, M.D., JD There is no cost for this program. Target audience: Physicians, Nurses, Pharmacists Continuing Education Credit: Physicians: Maximum of 0.50 AMA PRA Category 1 Credit(s) ABIM Diplomates: Maximum of 0.50 ABIM […]
Taking Stewardship to the Next Level: Getting Providers to Commit to Antibiotic Indications and Durations of Therapy
PREVIOUSLY RECORDED: A division of one of the nation’s largest healthcare providers implemented an antimicrobial stewardship initiative in the summer of 2015, which promoted or required documentation of indications and durations with antibiotic prescriptions. This program will feature a review of the challenges and successes with implementation and the clinical outcome impact of the initiative both from the perspective of the division which implemented the program and small and large hospitals in Virginia and New Hampshire.
PREVIOUSLY RECORDED: Beta-lactams are the most commonly prescribed class of antimicrobials. Initial reports cite a cross reactivity rate ranging from 0.7 to 10 percent between penicillin and cephalosporin antibiotics, while penicillins are the most common cause of drug induced anaphylaxis, with a risk of 0.01 to 0.05 percent. Fear of cross-reactions among beta-lactams leads to the use of alternative or broader antibiotics, the use of possibly inferior antibiotics, increased healthcare costs and development of bacterial resistance. This program will evaluate the use of cephalosporins and carbapenems in penicillin-allergic patients, based on a literature review and the experience of a large community hospital.
Healthy Food in Healthcare, Part 3: The Role of Procurement in Preventing Antibiotic Overuse in Food Production
PREVIOUSLY RECORDED: This webinar will focus on how hospitals can use their purchasing power to engage in cross-sector or market transformation procurement strategies to prevent antibiotic overuse in food production while still making the business case.
Healthy Food in Healthcare, Part 2: Opportunities for Health Professional Engagement: Clinical Advocacy on Policies and Procurement Resolutions
PREVIOUSLY RECORDED: This webinar will feature three physicians active in efforts to promote comprehensive antibiotic stewardship using a three-pronged approach: clinical practice, food purchasing and policy advocacy. Current research will be reviewed and tangible suggestions about how health professionals, particularly clinicians, can serve as leaders in stewardship of antibiotics in food production will be discussed.
Healthy Food in Healthcare, Part 1: Foundations: Emerging Science, Food Production Practices and Federal Policy
PREVIOUSLY RECORDED: This webinar will outline the foundational issues around antibiotic use in animal agriculture, and provide an overview of the current policy landscape.